Cell Surface Sialomucin and Resistance to Natural Cell-mediated Cytotoxicity of Rat Mammary Tumor Ascites Cells1
نویسندگان
چکیده
MAT-B1 and M A I -( 1 ascites subîmes of the 13762 rat mammary adenocarcinoma both contain sialomucin as a major cell surface compo nent and are resistant to cytolysis by normal rat spleen lymphocytes |3 ±2% (SD) and O ±1%, respectively). Susceptibility to lysis did not increase following treatment of cells with neuraminidase, fucosidase, or aor 0-galactosidase. Treatment with trypsin significantly increased the susceptibility of MAT-B1 (14 ±3%) but not MAT-CI (5 ±2%). Following 1 month in culture, the sialomucin content of MAT-B1 cells dropped from 30% to 8% (determined by glucosamine labeling) and natural cell-mediated cytolysis increased to 16 ±4%, whereas the sialo mucin content and susceptibility of MAT-CI cells did not change. The results indicate that the relatively minor changes associated with removal of cell surface sialic acid or fucose residues do not result in increased susceptibility of the ascites cells to cytolysis. However, susceptibility of M VI-HI cells to lysis by normal rat spleen lymphocytes was inversely correlated with the amount of major glycoprotein (i = —0.96).
منابع مشابه
Cell surface sialomucin and resistance to natural cell-mediated cytotoxicity of rat mammary tumor ascites cells.
MAT-B1 and MAT-C1 ascites sublines of the 13762 rat mammary adenocarcinoma both contain sialomucin as a major cell surface component and are resistant to cytolysis by normal rat spleen lymphocytes [3 +/- 2% (SD) and 0 +/- 1%, respectively]. Susceptibility to lysis did not increase following treatment of cells with neuraminidase, fucosidase, or alpha- or beta-galactosidase. Treatment with trypsi...
متن کاملSialomucin and lytic susceptibility of rat mammary tumor ascites cells.
The potential role of cell surface sialomucin in preventing natural killer (NK)-mediated lysis of tumor cell targets has been addressed by comparing the properties of 2 NK-resistant [ascites (ASC) and short-term cultured (STC)] and 2 NK-susceptible [tunicamycin-treated (TUN) and long-term cultured (LTC)] preparations of 13762 MAT-B1 rat mammary tumor cells. Both the ASC and STC cell preparation...
متن کاملEffect of tunicamycin on sialomucin and natural killer susceptibility of rat mammary tumor ascites cells.
The MAT-B1 and MAT-C1 ascites sublines of the 13762 rat mammary adenocarcinoma contain a dominant cell surface "complex" consisting of two glycoproteins: ascites sialoglycoprotein (ASGP)-1, a Mr 600,000-700,000 peanut agglutinin-binding sialomucin, and ASGP-2, a Mr 120,000 concancavalin A-binding glycoprotein (Sherblom et al., J. Biol. Chem., 255: 783-790, 1980; Sherblom and Carraway, J. Biol. ...
متن کاملExpression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity.
Crry is a rodent membrane-bound inhibitor of complement activation and is a structural and functional analog of the human complement inhibitors decay-accelerating factor and membrane cofactor protein. We found previously that expression of rat Crry on a human tumor cell line enhances tumorigenicity in nude rats. In this study, we investigated the effect that rat Crry expressed on tumor cells ha...
متن کاملCells MUC4, Inhibits Tumor Killing by Lymphokine-activated Killer Overexpression of Sialomucin Complex, a Rat Homologue of Updated Version
Sialomucin complex (SMC) is a large heterodimeric glycoprotein complex composed of a mucin subunit ascites sialoglycoprotein-1 and a transmembrane subunit ascites sialoglycoprotein-2. It is a rat homologue of human mucin gene MUC4 and is abundantly expressed on the cell surface of highly metastatic ascites 13762 rat mammary adenocarcinoma cells. Because of their extended and rigid structures, m...
متن کامل